Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes.
Holzberg D, Knight CG, Dittrich-Breiholz O, Schneider H, Dörrie A, Hoffmann E, Resch K, Kracht M. Holzberg D, et al. Among authors: dorrie a. J Biol Chem. 2003 Oct 10;278(41):40213-23. doi: 10.1074/jbc.M304058200. Epub 2003 Jun 27. J Biol Chem. 2003. PMID: 12832416 Free article.
Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes.
Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, Graue N, Dörrie A, Schneider H, Wirth D, Luckow B, Resch K, Kracht M. Thiefes A, et al. Among authors: dorrie a. J Biol Chem. 2005 Jul 29;280(30):27728-41. doi: 10.1074/jbc.M411657200. Epub 2005 Apr 18. J Biol Chem. 2005. PMID: 15837794 Free article.
The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation.
Holtmann H, Enninga J, Kalble S, Thiefes A, Dorrie A, Broemer M, Winzen R, Wilhelm A, Ninomiya-Tsuji J, Matsumoto K, Resch K, Kracht M. Holtmann H, et al. Among authors: dorrie a. J Biol Chem. 2001 Feb 2;276(5):3508-16. doi: 10.1074/jbc.M004376200. Epub 2000 Oct 24. J Biol Chem. 2001. PMID: 11050078 Free article.
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1.
Schwarzer A, Oliveira M, Kleppa MJ, Slattery SD, Anantha A, Cooper A, Hannink M, Schambach A, Dörrie A, Kotlyarov A, Gaestel M, Hembrough T, Levine J, Luther M, Stocum M, Stiles L, Weinstock DM, Liesa M, Kostura MJ. Schwarzer A, et al. Among authors: dorrie a. Mol Cancer Ther. 2023 Nov 1;22(11):1290-1303. doi: 10.1158/1535-7163.MCT-22-0718. Mol Cancer Ther. 2023. PMID: 37643767 Free PMC article.
On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer.
Boudghene-Stambouli F, Soulez M, Ronkina N, Dörrie A, Kotlyarov A, Seternes OM, Gaestel M, Meloche S. Boudghene-Stambouli F, et al. Among authors: dorrie a. Cancers (Basel). 2022 Dec 21;15(1):25. doi: 10.3390/cancers15010025. Cancers (Basel). 2022. PMID: 36612022 Free PMC article.